Neuro-Oncology Reviews
Volume
24 Number 1
15 January 2022
Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 1, 15 January
Masood
M, Anwar RF, Mehmood K, Javed M, Amjad T, Naseem N.
Analysis
of Isocitrate
dehydrogenase (IDH) mutation in Gliomas: A call for neurosurgeons
and pathologists
in Pakistan.
J
Pak Med Assoc. 2022 Jan;72(1):134-140→.
doi: 10.47391/JPMA.2342→.
PMID: 35099452→.
Review. ˍ
Zhu
Y, Zhao L, Xu Y, Zhan W, Sun X, Xu X.
Combining
apatinib and temozolomide
for
brainstem glioblastoma: a case report and review of
literature.
Ann
Palliat Med. 2022 Jan;11(1):394-400→.
doi: 10.21037/apm-22-22→.
PMID: 35144430→.
Case report, Review. ˍ
Liu
D, Yang T, Ma W, Wang Y.
Clinical
strategies to manage adult glioblastoma
patients
without MGMT hypermethylation.
J
Cancer. 2022 Jan 1;13(1):354-363→.
doi: 10.7150/jca.63595→.
PMID: 34976195→.
Review. ˍ
Pehlivan
KC, Paul MR, Crawford JR.
Central
Nervous System Tumors in Children.
Pediatr
Rev. 2022 Jan 1;43(1):3-15→.
doi: 10.1542/pir.2020-004499→.
PMID: 34970690→.
Review˰ ˍ
Chen
JS, Clarke R, Haddad AF, Wang EJ, Lacroix M, Sarkar IN, Zand R,
Chen ES, Toms SA.
The
effect of levetiracetam treatment on survival in patients with
glioblastoma:
a systematic review and meta-analysis.
J
Neurooncol. 2022 Jan 4;156(2):257-267→.
doi: 10.1007/s11060-021-03940-2→.
PMID: 34982371→.
Review, Meta-analysis˰ ˍ
do
Nascimento RP, Dos Santos BL, Amparo JAO, Soares JRP, da Silva KC,
Santana MR, Almeida ÁMAN, da Silva VDA, Costa MFD, Ulrich
H, Moura-Neto V, Lopes GPF, Costa SL.
Neuroimmunomodulatory
Properties of Flavonoids and Derivates: A
Potential
Action as Adjuvants for the Treatment of
Glioblastoma.
Pharmaceutics.
2022 Jan 4;14(1):116→.
doi: 10.3390/pharmaceutics14010116→.
PMID: 35057010→.
Review. ˍ
Zhang
Y, Chen S, Chen H, Chen S, Li Z, Feng E, Li W.
Prognostic
Value and Risk
Factors of Treatment-Related Lymphopenia in Malignant Glioma
Patients Treated
With Chemoradiotherapy: A Systematic Review and
Meta-Analysis.
Front
Neurol. 2022 Jan 4, 2021;12:726561→.
doi: 10.3389/fneur.2021.726561→.
PMID: 35058869→.
Review, Meta-analysis. ˍ
Annu,
Rehman S, Nabi B, Sartaj A, Baboota S, Md S, Sahoo PK, Ali
J.
Nanoparticle
mediated gene therapy: a trailblazer armament to fight CNS
disorders.
Curr
Med Chem. 2022 Jan 5, 2023;30(3):304-315→.
doi: 10.2174/0929867329666220105122318→.
PMID: 34986767→.
Review˰ ˍ
Eatz
TA, Eichberg DG, Lu VM, Di L, Komotar RJ, Ivan ME.
Intraoperative
5-ALA
fluorescence-guided
resection of high-grade glioma leads to greater extent of
resection
with better outcomes: a systematic review.
J
Neurooncol. 2022 Jan 6;156(2):233-256→.
doi: 10.1007/s11060-021-03901-9→.
PMID: 34989964→.
Review˰ ˍ
Li
R, Wang H, Liang Q, Chen L, Ren J.
Radiotherapy
for glioblastoma: clinical
issues
and nanotechnology strategies.
Biomater
Sci. 2022 Jan 6;10(4):892-908→.
doi: 10.1039/d1bm01401c→.
PMID: 34989724→.
Review˰ ˍ
Soffietti
R, Bettegowda C, Mellinghoff IK, Warren KE, Ahluwalia MS, De Groot
JF, Galanis E, Gilbert MR, Jaeckle KA, Le Rhun E, Rudà R,
Seoane J, Thon N, Umemura Y, Weller M, van den Bent MJ, Vogelbaum
MA, Chang SM, Wen PY.
Liquid
biopsy
in gliomas: a RANO review and proposals for clinical
applications.
Neuro
Oncol. 2022 Jan 6;24(6):855-871→.
doi: 10.1093/neuonc/noac004→.
PMID: 34999836→.
Review. ˍ
Șovrea
AS, Boșca B, Melincovici CS, Constantin AM, Crintea A,
Mărginean M, Dronca E, Jianu ME, Suflețel R, Gonciar D,
Bungărdean M, Crivii CB.
Multiple
Faces
of the Glioblastoma Microenvironment.
Int
J Mol Sci. 2022 Jan 6;23(2):595→.
doi: 10.3390/ijms23020595→.
PMID: 35054779→.
Review. ˍ
Ritchey
AK,
et al., PDQ Pediatric
Treatment Editorial Board.
Childhood
Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment
(PDQ®): Patient Version.
PDQ
Cancer Inf Summ.
2022 Jan
7→.
Bookshelf ID:
NBK65903→.
PMID:
26389341→.
Review.
ˍ
Chawla
S, Kavouridis VK, Boaro A, Korde R, Amaral Medeiros S, Edrees H,
Mezzalira E, Sala F, Mekary RA, Smith TR.
Surgery
vs. Biopsy in the Treatment of
Butterfly
Glioblastoma: A Systematic Review and Meta-Analysis.
Cancers
(Basel). 2022 Jan 9;14(2):314→.
doi: 10.3390/cancers14020314→.
PMID: 35053478→.
Review. ˍ
Dhar
D, Ghosh S, Das S, Chatterjee J.
A
review of recent advances in magnetic
nanoparticle-based
theranostics of glioblastoma.
Nanomedicine
(Lond). 2022 Jan 10, 2021;17(2):107-132→.
doi: 10.2217/nnm-2021-0348→.
PMID: 35000429→.
Review˰ ˍ
Gatto
L, Franceschi E, Tosoni A, Di Nunno V, Bartolini S, Brandes
AA.
Molecular
Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma
Treatment?
Cancers
(Basel). 2022 Jan 11;14(2):333→.
doi: 10.3390/cancers14020333→.
PMID: 35053495→.
Review. ˍ
Kraus
TFJ, Schwartz C, Machegger L, Zellinger B, Hölzl D, Schlicker
HU, Pöppe J, Ladisich B, Spendel M, Kral M, Sotlar K.
A
patient with two gliomas with
independent
oligodendroglioma and glioblastoma biology proved by
DNA-methylation
profiling:
a case report and review of the literature.
Brain
Tumor Pathol. 2022 Jan 11;39(2):111-119→.
doi: 10.1007/s10014-021-00423-0→.
PMID: 35018523→.
Case report, Review. ˍ
*
Krapež
G, Kouter K, Jovčevska I, Videtič Paska A.
Dynamic
Intercell
Communication
between Glioblastoma and Microenvironment through Extracellular
Vesicles.
Biomedicines.
2022 Jan 11;10(1):151→.
doi: 10.3390/biomedicines10010151→.
PMID: 35052830→.
Review. ˍ
Roberts
A, Roughley M, Wilkinson C.
Glioblastoma:
The Weed of the Brain.
J
Vis
Commun Med. 2022 Jan 11;45(2):54-60→.
doi: 10.1080/17453054.2021.2010521→.
PMID: 35012411→.
Perspective. ˍ
Aftab
K, Aamir FB, Mallick S, Mubarak F, Pope WB, Mikkelsen T, Rock JP,
Enam SA.
Radiomics
for precision medicine in glioblastoma.
J
Neurooncol. 2022 Jan 12;156(2):217-231→.
doi: 10.1007/s11060-021-03933-1→.
PMID: 35020109→.
Review˰ ˍ
*
Jain
S, Chalif EJ, Aghi MK.
Interactions
Between Anti-Angiogenic Therapy and
Immunotherapy
in Glioblastoma.
Front
Oncol. 2022 Jan 12, 2021;11:812916→.
doi: 10.3389/fonc.2021.812916→.
PMID: 35096619→.
Review. ˍ
Lee
J, Troike K, Fodor R, Lathia JD.
Unexplored
functions of sex hormones in
glioblastoma
cancer stem cells.
Endocrinology.
2022 Jan 12;163(3):bqac002→.
doi: 10.1210/endocr/bqac002→.
PMID: 35023543→.
Review˰
ˍ
Njonkou
R, Jackson CM, Woodworth GF, Hersh DS.
Pediatric
glioblastoma:
mechanisms
of immune evasion and potential therapeutic opportunities.
Cancer
Immunol Immunother. 2022 Jan 12;71(8):1813-1822→.
doi: 10.1007/s00262-021-03131-y→.
PMID: 35020009→.
Review˰ ˍ
Zhao
S, Xu B, Ma W, Chen H, Jiang C, Cai J, Meng X.
DNA
Damage Repair in
Brain
Tumor Immunotherapy.
Front
Immunol. 2022 Jan 13, 2021;12:829268→.
doi: 10.3389/fimmu.2021.829268→.
PMID: 35095931→.
Review. ˍ
Ferrara
G.
Abstracts
of the Fourth Brainstorming Research Assembly for Young
Neuroscientists
(BraYn), Italy, 20-22 October 2021.
Neurol
Int. 2022 Jan 14;14(1):109-157→.
doi: 10.3390/neurolint14010010→.
PMID: 35076571→.
Meeting abstracts. ˍ
Paslaru
FG, Panaitescu AM, Nestian E, Iancu G, Veduta A, Paslaru AC, Pop
LG, Gorgan RM.
Medulloblastoma
Presenting as Severe Headache during Pregnancy: A
Case
Report and Review of the Literature.
Medicina
(Kaunas). 2022 Jan 14;58(1):127→.
doi: 10.3390/medicina58010127→.
PMID: 35056435→.
Case report, Review. ˍ